U.S. government health officials approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been shown to help slow the brain-destroying disease. The Food and Drug Administration (FDA) said it granted approval to the drug from Biogen based on results that seemed “reasonably likely” to benefit Alzheimer's patients. (CTV News)
Category:
Published on: 10 Jun 2021
Category:
Published on: 5 Jan 2015
Category:
Published on: 2 Jan 2015
Category:
Published on: 15 Jul 2014